Lack of effect of steroids on thyrotropin-releasing hormone (TRH) mediated thyrotropin (TSH) release in man. 1973

P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003348 Cortisone A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D004054 Diethylstilbestrol A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) Stilbestrol,Agostilben,Apstil,Diethylstilbestrol, (Z)-Isomer,Diethylstilbestrol, Disodium Salt,Distilbène,Stilbene Estrogen,Tampovagan,Estrogen, Stilbene
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
October 1972, The Journal of clinical endocrinology and metabolism,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
January 1972, Hormones,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
March 1973, The Journal of clinical endocrinology and metabolism,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
April 1986, Nihon Ika Daigaku zasshi,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
January 1982, Psychoneuroendocrinology,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
January 1985, Peptides,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
April 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
November 1972, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
January 1978, Communications in psychopharmacology,
P D Woolf, and D Gonzalez-Barcena, and D S Schalch, and L A Lee, and J P Arzac, and A V Schally, and A J Kastin
June 1970, General and comparative endocrinology,
Copied contents to your clipboard!